These results suggest that the AMPK signaling was inhibited and the NF-κB signaling was activated in the progression of NAFLD/NASH induced by HFD/HFHC diet. This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatotic liver disease.